Dmytro BІLYI, Mykhailo RUBLENKO, Liudmyla KOVALOVA, Dmytro SLIUSARENKO, Liudmyla HALUZINA, Oleksandr STOTSKYI, Sergey MASLIKOV

Clinical and hemostasis predictors of mammary gland tumors in bitches

This study presents the results of the study of clinical and hemostasis predictors of mammary gland tumors in bitches, which allow to determine the risk groups for this disease. The highest incidence rates were found in German and Eastern European Shepherds (22.1%), Dachshunds (12.8%) and Yorkshire terriers (9.5%) when kept in private households: 97.1%, 96.3% and 97.3%, respectively. Significantly increases the likelihood of mammary gland cancer in excess body weight – by 30%–100%, in the case of mixed feeding – up to 39.3%, the use of hormonal contraceptives – by 50%–60%. Adverse prognosis correlates with an increase in the size, nature of the surface and the relationship with the surrounding tissues of the lesion, localization in 4th and 5th pairs of the mammary glands. Progression of the disease is accompanied by the development of hypercoagulable syndrome, which is characterized by an increase in fibrinogen and soluble fibrin due to activation of external and internal coagulation pathways, as evidenced by the prolongation of activated partial thromboplastin and prothrombin time. The results of the screening can be used for prevention and early diagnosis of the disease, as well as the development of promising treatment protocols.

PDF

___

1. Raduly L, Cojocneanu-Petric R, Sarpataki O, Chira S, Atanasov AG et al. Canis lupus familiaris as relevant animal model for breast cancer - a comparative oncology review. Animal Science Papers & Reports 2018; 36 (2): 119-148.
2. Visan S, Balacescu O, Berindan-Neagoe I, Catoi C. In vitro comparative models for canine and human breast cancers. Clujul Medical 2016; 89 (1): 38-49. doi: 10.15386/cjmed-519
3. Korkmaz U, Ustun F. Experimental breast cancer models: preclinical imaging perspective. Current Radiopharmaceuticals 2020. doi: 10.2174/1874471013666200508080250
4. Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Developmental Cell 2010; 18 (6): 884-901. doi: 10.1016/j.devcel.2010.05.012
5. Matos AJF, Baptista CS, Gärtner MF, Rutteman GR. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures. The Veterinary Journal Volume 2012; 193 (1): 24-31. doi: 10.1016/j.tvjl.2011.12.019
6. Paoloni M, Webb C, Mazcko C, Cherba D, Hendricks W et al. Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine trials. PLoS ONE 2014; 9 (3): e90028. doi: 10.1371/journal.pone.0090028
7. McCarthy DO, Alvarez CE. Dog models of naturally occurring cancer. Trends in Molecular Medicine 2011; 17 (7): 380-388. doi: 10.1016/j.molmed.2011.02.004
8. Gupta K, Sood NK, Uppal SK, Mohindroo J, Mahajan S. Epidemiological studies on canine mammary tumour and its relevance for breast cancer studies. Journal of Pharmacy 2012; 2 (2): 322-333.
9. Cekanova M, Rathore K. Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Design, Development and Therapy 2014; 8: 1911-1922. doi: 10.2147/DDDT.S49584
10. Tan YJ, Crowley RJ, Ioannidis J. An empirical assessment of research practices across 163 clinical trials of tumor-bearing companion dogs. Scientific Reports 2019; 9 (1): 11877. doi: 10.1038/s41598-019-48425-5
11. Schmidt JM, North SM, Freeman KP. Canine paediatric oncology: retrospective assessment of 9522 tumours in dogs up to 12 months (1993-2008). Veterinary and Comparative Oncology 2011; 8 (4): 283-292. doi: 10.1111/j.1476- 5829.2010.00226.x
12. Andreasen E, Tranholm M, Wiinberg B, Markussen B, Kristensen A. Haemostatic alterations in a group of canine cancer patients are associated with cancer type and disease progression. Acta Veterinaria Scandinavica 2012; 54 (1). doi: 10.1186/1751-0147-54-3
13. Owen LN. TNM classification of tumors in domestic animals. Geneva, Switzerland: World Health Organization; 1980.
14. Firth AM, Haldane SL. Development of a scale to evaluate postoperative pain in dogs. Journal of the American Veterinary Medical Association 1999; 214 (5): 651-659.
15. Belicer VO, Varec’ka TV, Veremjejenko, KM. Kil’kisne vyznachennja fibrynogenu v plazmi krovi ljudyny [Quantitative determination of fibrinogen in human plasma]. Laboratorna Diagnostyka 1997; 2: 53-55 (in Ukrainian).
16. Vareckaja TV, Mihajlovskaja LI, Svital’skaja LA. Opredelenie rastvorimogo fibrina v plazme krovi [Determination of soluble fibrin in blood plasma]. Klinicheskaja Laboratornaja Diagnostika 1992; 7-8: 10-14 (in Russian).
17. Quick AJ. The Hemorragic Disease and the Pathology of Hemostasis. New York, NY, USA: Thomas Publishing; 1974. p. 111.
18. Goldschmidt M, Peña L, Rasotto R, Zappulli V. Classification and grading of canine mammary tumors. Veterinary Pathology 2011; 48 (1): 117-131. doi: 10.1177/0300985810393258
19. Vascellari M, Capello K, Carminato A, Zanardello C, Baioni E et al. Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): risk factors and similarities to human breast cancer. Preventive Veterinary Medicine 2016; 126: 183-189. doi: 10.1016/j. prevetmed.2016.02.008
20. Dobson J. Breed-predispositions to cancer in pedigree dogs. Veterinary Science 2013; 2013: 941275. doi: 10.1155/2013/941275
21. Cannas S, Berteselli GV, Piotti P, Talamonti Z, Scaglia E et al. Stress and cancer in dogs: comparison between a population of dogs diagnosed with cancer and a control population - a pilot study. Macedonian Veterinary Review 2016; 39 (2): 201-208. doi: 10.1515/macvetrev-2016-0088
22. Dong G, Wang D, Liang X, Gao H, Wang L. et al. Factors related to survival rates for breast cancer patients. International Journal of Clinical and Experimental Medicine 2014; 7 (10): 3719-3724.
23. Sorenmo KU, Kristiansen VM, Cofone MA, Shofer FS, Breen A-M. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Veterinary and Comparative Oncology 2009; 7 (3): 162-172. doi: 10.1111/j.1476- 5829.2009.00184.x
24. Ferreira E, Bertagnolli AC, Cavalcanti MF, Schmitt FC, Cassali GD. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours. Veterinary and Comparative Oncology 2009; 7 (4): 230-235. doi: 10.1111/j.1476-5829.2009.00193.x
25. Kumar K, Agrawal R, Pande N, Sharma S, Kumar B. Occurrence, clinico-haemato-biochemical and histopathological studies on mammary gland tumor in geriatric dogs. The Pharma Innovation Journal 2018; 7 (5): 301-304.
26. Gundim LF, De Araújo CP, Blanca WT, Guimarães EC, Medeiros AA. Clinical staging in bitches with mammary tumors: influence of type and histological grade. Canadian Journal of Veterinary Research 2016; 80 (4): 318-322.
27. Sahabi K, Rajendren SK, Foong JN, Selvarajah GT. Mammary gland tumours in the dog, a spontaneous tumour model of comparative value to human breast cancer. Pertanika Journal of Tropical Agricultural Science 2018; 41 (2): 541-574.
28. Santos TR, Castro JR, Andrade JC, Silva ACR, Silva GMF et al. Risk factors associated with mammary tumors in female dogs. Pesquisa Veterinária Brasileira 2020; 40 (6): 466-473.
29. Shafiee R, Javanbakht J, Atyabi N, Kheradmand P, Kheradmand D et al. Diagnosis, classification and grading of canine mammary tumours as a model to study human breast cancer: an clinico-cytohistopathological study with environmental factors influencing public health and medicine. Cancer Cell International 2013; 9 (13): 79. doi: 10.1186/1475-2867-13-79
30. Gomes JB, Ramires RM, Maldonado EJ. Presence of lung metastases in bitches affected by malignant mammary neoplasms in Medellin (Colombia). Revista MVZ Cordoba 2012; 17 (2): 2983-2990.
31. German AJ. The Growing problem of obesity in dogs and cats. The Journal of Nutrition 2006; 136 (7): 1940-1946. doi: 10.1093/ jn/136.7.1940S
32. Weeth LP, Fascetti AJ, Kass PH, Suter SE, Santos AM et al. Prevalence of obese dogs in a population of dogs with cancer. American Journal of Veterinary Research 2007; 68 (4): 389-398. doi: 10.2460/ajvr.68.4.389
33. Tesi M, Millanta F, Poli A, Mazzetti G, Pasquini Aet al. Role of body condition score and adiponectin expression in the progression of canine mammary carcinomas. Veterinary Medicine and Science 2020; 6 (3): 265-271. doi: 10.1002/vms3.238
34. Lim H, Im K, Kim N, Kim H, Shin J. Effects of obesity and obesityrelated molecules on canine mammary gland tumors. Veterinary Pathology 2015; 52: 1045-1051.
35. Shin J-I, Lim H-Y, Kim H-W, Seung B-J, Ju J-H et al. Analysis of obesity-related factors and their association with aromatase expression in canine malignant mammary tumours. Journal of Comparative Pathology 2016; 155 (1): 15-23. doi: 10.1016/j. jcpa.2016.05.005
36. Stone TW, McPherson M, Gail Darlington L. Obesity and cancer: existing and new hypotheses for a causal connection. EBioMedicine 2018; 30: 14-28. doi: 10.1016/j.ebiom.2018.02.022 37. Benavente MA, Bianchi CP, Aba MA. Canine mammary tumors: risk factors, prognosis and treatments. Journal of Veterinary Advances 2016; 6: 1291-1300.
38. Im KS, Kim NH, Lim HY, Kim HW, Shin JI. Analysis of a new histological and molecular-based classification of canine mammary neoplasia. Veterinary Pathology 2014; 51 (3): 549-559. doi: 10.1177/0300985813498780
39. Rasotto R, Berlato D, Goldschmidt MH, Zappulli V. Prognostic significance of canine mammary tumor histologic subtypes: an observational cohort study of 229 cases. Veterinary Pathology 2017; 54 (4): 571-578. doi: 10.1177/0300985817698208
40. Saad ES, Milley KM, Al-Khan AA, Nimmo JS, Bacci B. Canine mixed mammary tumour as a model for human breast cancer with osseous metaplasia. Journal of Comparative Pathology 2017; 156 (4): 352-365. doi: 10.1016/j.jcpa.2017.03.005
41. Kim HW, Lim HY, Shin JI, Seung BJ, Ju JH et al. Breed- and agerelated differences in canine mammary tumors. Canadian Journal of Veterinary Research 2016; 80 (2): 146-155.
42. Scarpa F, Sabattini S, Marconato L, Capitani O, Morini M et al. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision. Journal of the American Veterinary Medical Association 2012; 240 (10): 1181-1187. doi: 10.2460/javma.240.10.1181
43. Richards CH, Mohammed Z, Qayyum T, Horgan PG, McMillan DC. The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. Future Oncology 2011; 7 (10): 1223-1235. doi: 10.2217/fon.11.99
44. Peña L, Andrés PJD, Clemente M, Cuesta P, Pérez-Alenza MD. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics. Veterinary Pathology 2013; 50 (1): 94-105. doi: 10.1177/0300985812447830
45. Perez Alenza MD, Peña L, Del Castillo N, Nieto AI. Factors influencing the incidence and prognosis of canine mammary tumours. The Journal of Small Animal Practice 2000; 41 (7): 287-291. doi: 10.1111/j.1748-5827.2000.tb03203.x
46. Spodsberg E-MH, Wiinberg B, Jessen LR, Marschner CB, Kristensen AT. Endogenous fibrinolytic potential in tissueplasminogen activator-modified thromboelastography analysis is significantly decreased in dogs suffering from diseases predisposing to thrombosis. Veterinary Clinical Pathology 2013; 42 (3): 281-290. doi: 10.1111/vcp.12068
47. Gruber EJ, Catalfamo JL, Stokol T. Role of tissue factor expression in thrombin generation by canine tumor cells. American Journal of Veterinary Research 2016; 77 (4): 404- 412. doi: 10.2460/ajvr.77.4.404
48. Kobayashi K, Baba K, Igase M, Miyama TS, Kambayashi S. Microparticle-associated tissue factor activity in dogs with disseminated intravascular coagulation. Journal of Veterinary Medical 2020; 82 (1): 56-60. doi: 10.1292/jvms.19-0553
49. Saavedra PV, García AL, López SZ, Couto G. Hemostatic abnormalities in dogs with carcinoma: a thromboelastographic characterization of hypercoagulability. The Veterinary Journal 2011; 190 (2): 78-83. doi: 10.1016/j.tvjl.2011.02.025
50. Andreasen EB, Nielsen OL, Tranholm M, Knudsen T, Kristensen AT. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation. Veterinary and Comparative Oncology 2016; 14 (2): 191-201. doi: 10.1111/vco.12089
51. Bauer N, Moritz A. Coagulation response in dogs with and without systemic inflammatory response syndrome – preliminary results. Research in Veterinary Science 2013; 94 (1): 122-131. doi: 10.1016/j.rvsc.2012.07.029
52. Bely DD, Rublenko MV, Samoyuluk VV, Yevtushenko ID, Maslikov SN. Breast tumour size as a predictor of hemostatic system status and endothelial function in dogs. Regulatory Mechanisms in Biosystems 2019; 10 (3): 300-305. doi: 10.15421/021946
53. Jaillardon L, Barthélemy A, Goy-Thollot I, Pouzot-Nevoret C, Fournel-Fleury C. Mammary gland carcinoma in a dog with peripheral blood and bone marrow involvement associated with disseminated intravascular coagulation. Veterinary Clinical Pathology 2012; 41 (2): 261-265. doi: 10.1111/j.1939- 165X.2012.00433.x
54. McMahon B, Kwaan HC. The plasminogen activator system and cancer. Pathophysiology of Haemostasis and Thrombosis 2008; 36 (3-4): 184-194. doi: 10.1159/000175156
55. Rak J, Milsom C, May L, Klement P, Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Seminars in Thrombosis and Hemostasis 2006; 32 (1): 54-70. doi: 10.1055/s-2006-933341